These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11297218)

  • 1. Rise and fall of asthma-related mortality in Italy and sales of beta2-agonists, 1980-1994.
    Romano F; Recchia G; Staniscia T; Bonitatibus A; Villa M; Nicolosi A; De Carli G; Mannino S
    Eur J Epidemiol; 2000; 16(9):783-7. PubMed ID: 11297218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
    Lanes SF; Birmann B; Raiford D; Walker AM
    J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence based answers--is salmeterol safe in asthma?
    Spurling G; Doust J
    Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of on-demand beta2-agonist inhalation in moderate-to-severe asthma. A randomized controlled trial.
    Richter B; Bender R; Berger M
    J Intern Med; 2000 Jun; 247(6):657-66. PubMed ID: 10886487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.
    Suissa S; Ernst P; Boivin JF; Horwitz RI; Habbick B; Cockroft D; Blais L; McNutt M; Buist AS; Spitzer WO
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):604-10. PubMed ID: 8118625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End of the New Zealand asthma mortality epidemic.
    Pearce N; Beasley R; Crane J; Burgess C; Jackson R
    Lancet; 1995 Jan; 345(8941):41-4. PubMed ID: 7799709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deaths from asthma in Italy (1974-1988): is there a relationship with changing pharmacological approaches?
    Mormile F; Chiappini F; Feola G; Ciappi G
    J Clin Epidemiol; 1996 Dec; 49(12):1459-66. PubMed ID: 8970498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta2-agonist eutomers: a rational option for the treatment of asthma?
    Boulton DW; Fawcett JP
    Am J Respir Med; 2002; 1(5):305-11. PubMed ID: 14720033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: "Confounding by indication and channeling over time: the risks of beta2-agonists".
    Pearce N; Beasley R; Crane J; Burgess C
    Am J Epidemiol; 1997 Nov; 146(10):885-7. PubMed ID: 9384211
    [No Abstract]   [Full Text] [Related]  

  • 11. Stopping long-acting beta-2 agonists.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):21. PubMed ID: 20336032
    [No Abstract]   [Full Text] [Related]  

  • 12. Confounding by indication and channeling over time: the risks of beta 2-agonists.
    Blais L; Ernst P; Suissa S
    Am J Epidemiol; 1996 Dec; 144(12):1161-9. PubMed ID: 8956629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-agonist therapy and asthma mortality in Japan.
    Beasley R; Nishima S; Pearce N; Crane J
    Lancet; 1998 May; 351(9113):1406-7. PubMed ID: 9593418
    [No Abstract]   [Full Text] [Related]  

  • 14. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ; Jaeschke R
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is new with the beta2-agonists: issues in the management of asthma.
    Kelly HW
    Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma deaths in New Zealand: whodunnit?
    Blauw GJ; Westendorp RG
    Lancet; 1995 Jan; 345(8941):2-3. PubMed ID: 7799701
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of beta-agonists and the risk of death and near death from asthma.
    Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
    N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. What are the risks of using inhaled long-acting beta-agonist medications for the relief of asthma?
    Ann Intern Med; 2006 Jun; 144(12):I30. PubMed ID: 16785474
    [No Abstract]   [Full Text] [Related]  

  • 20. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic.
    Suissa S; Ernst P
    J Clin Epidemiol; 1997 Oct; 50(10):1079-88. PubMed ID: 9368515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.